Related Experiment Videos
Leukotriene receptors in rhinitis and sinusitis
1Asthma and Allergic Disease Center, Beirne Carter Center for Immunology Research, University of Virginia Health System, Charlottesville, 22908-1355, USA.
Current Allergy and Asthma Reports
|April 2, 2004
Summary
Cysteinyl leukotrienes (CysLTs) exert effects via CysLT1 and CysLT2 receptors. Targeting both receptor types or CysLT synthesis is crucial for inhibiting inflammation.
Area of Science:
- Immunology
- Pharmacology
Background:
- Cysteinyl leukotrienes (CysLTs) are key mediators of biologic activities.
- These activities are primarily mediated through interactions with CysLT1 and CysLT2 receptors.
Purpose of the Study:
- To delineate the distinct cellular expression patterns and functional roles of CysLT1 and CysLT2 receptors.
- To explore therapeutic strategies for comprehensive inhibition of CysLT-driven inflammation.
Main Methods:
- Receptor expression analysis across various cell types.
- Functional assays to determine CysLT-mediated cellular responses.
Main Results:
- CysLT1 receptors are primarily on smooth muscle cells, lung fibroblasts, and neutrophils.
- CysLT2 receptors are found on heart Purkinje fibers, adrenal chromaffin cells, endothelial cells, and antigen-presenting cells.
- Both receptors are present on eosinophils and mast cells, with distinct roles in bronchospasm, endothelial adherence, and chemokine production.
Conclusions:
- CysLT1 receptors are critical for mediating bronchospasm.
- CysLT2 receptors contribute to endothelial cell activation and inflammatory mediator release.
- Comprehensive blockade of CysLT-mediated inflammation may necessitate combined CysLT1/CysLT2 receptor antagonism or inhibition of CysLT synthesis.